Last reviewed · How we verify
Psoriatic Arthritis with Distal Interphalangeal Involvement
Approved treatments
- tumor necrosis factor inhibitors (TNFi) · Pfizer
- TNF Inhibitor · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Psoriatic Arthritis with Distal Interphalangeal Involvement patent landscape — cliff calendar, originator estates, attackable patents
- Psoriatic Arthritis with Distal Interphalangeal Involvement treatment landscape brief
- Psoriatic Arthritis with Distal Interphalangeal Involvement treatment updates RSS
Frequently asked questions about Psoriatic Arthritis with Distal Interphalangeal Involvement
What drugs treat Psoriatic Arthritis with Distal Interphalangeal Involvement?
Tracked treatments include tumor necrosis factor inhibitors (TNFi), TNF Inhibitor.
What is the treatment for Psoriatic Arthritis with Distal Interphalangeal Involvement?
Standard treatment for Psoriatic Arthritis with Distal Interphalangeal Involvement includes tumor necrosis factor inhibitors (TNFi), TNF Inhibitor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Psoriatic Arthritis with Distal Interphalangeal Involvement patent cliff · Psoriatic Arthritis with Distal Interphalangeal Involvement CI report
- Treatment: tumor necrosis factor inhibitors (TNFi) · Pfizer
- Treatment: TNF Inhibitor · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing